Brain tumor classification is a significant task for evaluating tumors and selecting the type of treatment as per their classes. Brain tumors are diagnosed using multiple imaging techniques. However, MRI is frequently utilized since it provides greater image quality and uses non-ionizing radiation. Deep learning (DL) is a subfield of machine learning and recently displayed impressive performance, particularly in segmentation and classifying problems. Based on convolutional neural network (CNN), a Hybrid Deep Learning Network (HDLN) model is proposed in this research for classifying multiple types of brain tumors including glioma, meningioma, and pituitary tumors. The Mask RCNN is used for brain tumor classification. We used a squeeze-and-excitation residual network (SE-ResNet) for brain tumor segmentation, which is a residual network (ResNet) with a squeeze-and-excitation block. A publicly available research dataset is used for testing the proposed model for experiment analysis and it obtained an overall accuracy of 98.53%, 98.64% sensitivity and 98.91% specificity. In comparison to the most advanced classification models, the proposed model obtained the best accuracy. For multi-class brain tumor diseases, the proposed HDLN model demonstrated its superiority to the existing approaches.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.